Wechlser listed exclusion criteria for therapy with intravenous tissue plasminogen activator (t-PA) for a patient with an ischemic stroke. These can help to identify patients more likely to benefit from the therapy than to suffer a serious complication. The criteria are based on those of Jauch et al. The author is from the University of Pittsburgh.

To read more or access our algorithms and calculators, please log in or register.